Location of mutations within the PKD2 gene influences clinical outcome.

BACKGROUND Since the cloning of the gene for autosomal dominant polycystic kidney disease type 2 (PKD2), approximately 40 different mutations of that gene have been reported to be associated with the disease. The relationship between the PKD2 genotype and phenotype, however, remains unclear. METHODS Detailed clinical information was collected for PKD2 families in which the underlying mutation had been identified. Logistic regression analysis was employed to assess the influence of age and sex on hypertension, hematuria, renal calculi, and urinary tract infections, and a clinical phenotype score was computed. Patients were then grouped according to the relative location of their mutation within the cDNA sequence, and differences in the mean phenotypic score between groups were tested for statistical significance by means of a multiple pairwise t-test. RESULTS While phenotypic scores for each mutational group revealed a considerable degree of intragroup variability, the variability in phenotypic scores was significantly higher between mutational groups than within groups. A group-wise comparison of the mean phenotypic scores confirmed the observation of significant nonlinear variation in disease severity, with high- and low-scoring mutational groups interspersed along the gene sequence. CONCLUSION The identification of groups of mutations in the PKD2 gene, which differ significantly with respect to clinical outcome, is to our knowledge the first description of a genotype/phenotype correlation in autosomal dominant polycystic kidney disease. It also provides evidence against complete loss of function of the mutant PKD2 gene product.

[1]  L. Sandkuijl,et al.  Genetic heterogeneity of polycystic kidney disease in Europe. , 1992, Contributions to nephrology.

[2]  V. Álvarez,et al.  A family with a milder form of adult dominant polycystic kidney disease not linked to the PKD1 (16p) or PKD2 (4q) genes. , 1997, Journal of medical genetics.

[3]  V. Sukhatme,et al.  Homo- and heterodimeric interactions between the gene products of PKD1 and PKD2. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Siep Thomas,et al.  THE POLYCYSTIC KIDNEY-DISEASE-1 GENE ENCODES A 14-KB TRANSCRIPT AND LIES WITHIN A DUPLICATED REGION ON CHROMOSOME-16 , 1994 .

[5]  G. Germino,et al.  PKD1 interacts with PKD2 through a probable coiled-coil domain , 1997, Nature Genetics.

[6]  X. Estivill,et al.  Facilitated diagnosis of the contiguous gene syndrome: tuberous sclerosis and polycystic kidneys by means of haplotype studies. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  P. Holmans,et al.  Familial phenotype differences in PKD11. , 1999, Kidney international.

[8]  Dalgaard Oz.  Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. , 1957 .

[9]  S. Somlo,et al.  Characterization of the exon structure of the polycystic kidney disease 2 gene (PKD2). , 1997, Genomics.

[10]  Patricia A. Gabow,et al.  PKD2, a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein , 1996, Science.

[11]  P. Ratcliffe,et al.  Polycystin, the polycystic kidney disease 1 protein, is expressed by epithelial cells in fetal, adult, and polycystic kidney. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  P. Gabow,et al.  Autosomal dominant polycystic kidney disease. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[13]  Ann M. Johnson,et al.  Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. , 1992 .

[14]  Ian Tomlinson,et al.  The type of somatic mutation at APC in familial adenomatous polyposis is determined by the site of the germline mutation: a new facet to Knudson's 'two-hit' hypothesis , 1999, Nature Medicine.

[15]  R. Richards,et al.  Phenotype and genotype heterogeneity in autosomal dominant polycystic kidney disease , 1992, The Lancet.

[16]  L. Agodoa,et al.  Autosomal dominant polycystic kidney disease: symptoms and clinical findings. , 1984, The Quarterly journal of medicine.

[17]  S. Somlo,et al.  Evidence for a third genetic locus for autosomal dominant polycystic kidney disease. , 1995 .

[18]  P. Bork,et al.  Polycystic kidney disease: The complete structure of the PKD1 gene and its protein , 1995, Cell.

[19]  G. Germino,et al.  The Molecular Basis of Focal Cyst Formation in Human Autosomal Dominant Polycystic Kidney Disease Type I , 1996, Cell.

[20]  V. Torres,et al.  New insights into polycystic kidney disease and its treatment , 1998, Current opinion in nephrology and hypertension.

[21]  E. Henske,et al.  Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. , 1997, The Journal of clinical investigation.

[22]  R. Kucherlapati,et al.  Somatic Inactivation of Pkd2 Results in Polycystic Kidney Disease , 1998, Cell.

[23]  L. Kunkel,et al.  The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. , 1989, American journal of human genetics.

[24]  C. Charasse,et al.  [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region]. , 1996, Nephrologie.

[25]  D. Tellería,et al.  Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease. , 1999, Kidney international.

[26]  E. Coto,et al.  Comparison of phenotypes of polycystic kidney disease types 1 and 2 , 1999, The Lancet.

[27]  J. Hughes,et al.  Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease — a contiguous gene syndrome , 1994, Nature Genetics.

[28]  R. Fossdal,et al.  A spectrum of mutations in the second gene for autosomal dominant polycystic kidney disease (PKD2). , 1997, American journal of human genetics.

[29]  R. G. Walker,et al.  Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1 , 1994, The Lancet.

[30]  A. Paterson,et al.  A novel frameshift mutation induced by an adenosine insertion in the polycystic kidney disease 2 (PKD2) gene. , 1998, Kidney international.

[31]  J. Hughes,et al.  The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains , 1995, Nature Genetics.

[32]  A. Paterson,et al.  A spectrum of mutations in the polycystic kidney disease-2 (PKD2) gene from eight Canadian kindreds. , 1998, Journal of the American Society of Nephrology : JASN.

[33]  S. Antonarakis.  Recommendations for a nomenclature system for human gene mutations , 1998 .

[34]  S. Somlo,et al.  A translation frameshift mutation induced by a cytosine insertion in the polycystic kidney disease 2 gene (PDK2). , 1997, Human molecular genetics.

[35]  S. Somlo,et al.  Novel stop and frameshifting mutations in the autosomal dominant polycystic kidney disease 2 (PKD2) gene , 1997, Human Genetics.

[36]  X. Estivill,et al.  Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2. , 1996, Journal of the American Society of Nephrology : JASN.

[37]  P. Holmans,et al.  Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. , 1997, Kidney international.

[38]  Y. Pei,et al.  Identification and localization of polycystin, the PKD1 gene product. , 1996, The Journal of clinical investigation.